- $251.50bn
- $1.02tn
- $119.66bn
REG - Nordea Bank Abp - Transaction in Own Shares
AnnouncementREG - Morgan Stanley&CoLLC Horizon Therapeutics - Rule 38.5_A -Horizon Therapeutics plc
AnnouncementREG - Morgan Stanley Cap - Rule 38.5_A -Horizon Therapeutics plc
AnnouncementREG - Nordea Bank Abp - Transaction in Own Shares
AnnouncementREG - Morgan Stanley Cap Horizon Therapeutics - Rule 38.5_A - Horizon Therapeutics plc
AnnouncementREG - Morgan Stanley & Co. Horizon Therapeutics - Rule 38.5_A -Horizon Therapeutics plc
AnnouncementREG - Morgan Stanley&CoLLC Horizon Therapeutics - Rule 38.5_A - Horizon Therapeutics plc
AnnouncementREG - Nordea Bank Abp - Transaction in Own Shares
AnnouncementREG - Morgan Stanley&CoLLC Horizon Therapeutics - Rule 38.5_A -Horizon Therapeutics plc
AnnouncementREG - Morgan Stanley & Co. Horizon Therapeutics - Form 38.5_A -Horizon Therapeutics plc
AnnouncementREG - Morgan Stanley Cap Horizon Therapeutics - Form 38.5_A -Horizon Therapeutics plc
AnnouncementREG - Nordea Bank Abp - Transaction in Own Shares
AnnouncementREG - Deliveroo PLC Morgan Stanley - Holding(s) in Company
AnnouncementREG - Morgan Stanley B.V. - Half-year Report
AnnouncementREG - Morgan Stanley & Co. Horizon Therapeutics - Rule 38.5_A -Horizon Therapeutics plc
AnnouncementREG - Morgan Stanley&CoLLC Horizon Therapeutics - Rule 38.5_A -Horizon Therapeutics plc
AnnouncementREG - Morgan Stanley Cap Horizon Therapeutics - Rule 38.5_A - Horizon Therapeutics plc
AnnouncementREG - Morgan Stanley&CoLLC Horizon Therapeutics - Rule 38.5_A - Horizon Therapeutics plc
AnnouncementREG - Morgan Stanley Cap Horizon Therapeutics - Rule 38.5_A - Horizon Therapeutics plc
Announcement